未登录 Pre-test prediction of multiple druggable mutations based on H&E image artificial intelligence (AI) analysis may enable more efficient clinical workflow for treatment decisions in non-small cell lung cancer (NSCLC) 基于H & E图像人工智能 (AI) 分析的多个可药物突变的测试前预测可以为非小细胞肺癌 (NSCLC) 的治疗决策提供更有效的临床工作流程 Lee, J.; Park, S.; Lee, S-H.; Choi, Y-L.; Choi, Y-D.; Noh, M-G.; Park, J.; Shin, S.; Lee, T.; Song, H.; Ro, J.; Moon, J.; Kim, S.; Ahn, C.; Pereira, S.; Yoo, D.; Ock, C-Y. 分享 收藏
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies 激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者减少palbociclib剂量后的血液学不良事件: 来自随机2期和3期研究的汇总分析 Ettl, Johannes; Im, Seock-Ah; Ro, Jungsil; Masuda, Norikazu; Colleoni, Marco; Schnell, Patrick; Bananis, Eustratios; Lu, Dongrui R.; Cristofanilli, Massimo; Rugo, Hope S.; Finn, Richard S. 分享 收藏
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2+metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) Sim, Sung Hoon; Park, In Hae; Jung, Kyung Hae; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Kyung-Hun; Im, Seock-Ah; Im, Young-Hyuck; Park, Yeon Hee; Sohn, Joohyuk; Kim, Yu Jung; Lee, Suee; Kim, Hee-Jun; Chae, Yee Soo; Park, Kyong Hwa; Nam, Byung-Ho; Lee, Keun Seok; Ro, Jungsil 分享 收藏
分享 收藏
Randomized phase II study of lapatinib plus vinorelbine versus vinorelbine in patients with HER2 positive metastatic breast cancer progressed after lapatinib and trastuzumab treatment Sim, S. H.; Park, I. H.; Jung, K. H.; Kim, S-B; Ahn, J-H; Lee, K-H; Im, S-A; Im, Y-H; Park, Y. H.; Sohn, J. H.; Kim, Y. J.; Lee, S.; Kim, H-J; Chae, Y. S.; Park, K-H; Nam, B-H; Lee, K. S.; Ro, J. 分享 收藏
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients Fujiwara, Yasuhiro; Mukai, Hirofumi; Saeki, Toshiaki; Ro, Jungsil; Lin, Yung-Chang; Nagai, Shigenori E.; Lee, Keun Seok; Watanabe, Junichiro; Ohtani, Shoichiro; Kim, Sung Bae; Kuroi, Katsumasa; Tsugawa, Koichiro; Tokuda, Yutaka; Iwata, Hiroji; Park, Yeon Hee; Yang, Youngsen; Nambu, Yoshihiro 分享 收藏
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer Palbociclib和Fulvestrant治疗晚期乳腺癌的总生存率 Turner, N. C.; Slamon, D. J.; Ro, J.; Bondarenko, I; Im, S-A; Masuda, N.; Colleoni, M.; DeMichele, A.; Loi, S.; Verma, S.; Iwata, H.; Harbeck, N.; Loibl, S.; Andre, F.; Puyana Theall, K.; Huang, X.; Giorgetti, C.; Huang Bartlett, C.; Cristofanilli, M. 分享 收藏
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study) Kim, Ji-Yeon; Im, Seock-Ah; Jung, Kyung Hae; Ro, Jungsil; Sohn, Joohyuk; Kim, Jee Hyun; Park, Yeon Hee; Kim, Tae-Yong; Kim, Sung-Bae; Lee, Keun Seok; Kim, Gun Min; Kim, Se Hyun; Kim, Seonwoo; Ahn, Jin Seok; Lee, Kyung-Hun; Ahn, Jin-Hee; Park, In Hae; Im, Young-Hyuck 分享 收藏
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (vol 28, pg 1700, 2017) Curigliano, G.; Burstein, H. J.; Winer, E. P.; Gnant, M.; Dubsky, P.; Loibl, S.; Colleoni, M.; Regan, M. M.; Piccart-Gebhart, M.; Senn, H. -J.; Thurlimann, B.; Andre, F.; Baselga, J.; Bergh, J.; Bonnefoi, H.; Brucker, S. Y.; Cardoso, F.; Carey, L.; Ciruelos, E.; Cuzick, J.; Denkert, C.; Di Leo, A.; Ejlertsen, B.; Francis, P.; Galimberti, V.; Garber, J.; Gulluoglu, B.; Goodwin, P.; Harbeck, N.; Hayes, D. F.; Huang, C. -S.; Huober, J.; Khaled, H.; Jassem, J.; Jiang, Z.; Karlsson, P.; Morrow, M.; Orecchia, R.; Osborne, K. C.; Pagani, O.; Partridge, A. H.; Pritchard, K.; Ro, J.; Rutgers, E. J. T.; Sedlmayer, F.; Semiglazov, V.; Shao, Z.; Smith, I.; Toi, M.; Tutt, A.; Viale, G.; Watanabe, T.; Whelan, T. J.; Xu, B. 分享 收藏
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al. Dubsky, P.; Curigliano, G.; Burstein, H. J.; Winer, E. P.; Gnant, M.; Loibl, S.; Colleoni, M.; Regan, M. M.; Piccart-Gebhart, M.; Senn, H. -J.; Thurlimann, B.; Andre, F.; Baselga, J.; Bergh, J.; Bonnefoi, H.; Brucker, S. Y.; Cardoso, F.; Carey, L.; Ciruelos, E.; Cuzick, J.; Denkert, C.; Di Leo, A.; Ejlertsen, B.; Francis, P.; Galimberti, V.; Garber, J.; Gulluoglu, B.; Goodwin, P.; Harbeck, N.; Hayes, D. F.; Huang, C. -S.; Huober, J.; Khaled, H.; Jassem, J.; Jiang, Z.; Karlsson, P.; Morrow, M.; Orecchia, R.; Osborne, K. C.; Pagani, O.; Partridge, A. H.; Pritchard, K.; Ro, J.; Rutgers, E. J. T.; Sedlmayer, F.; Semiglazov, V.; Shao, Z.; Smith, I.; Toi, M.; Tutt, A.; Viale, G.; Watanabe, T.; Whelan, T. J.; Xu, B. 分享 收藏
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 早期乳腺癌的降级和升级治疗: 早期乳腺癌主要治疗的圣加仑国际专家共识会议2017 Curigliano, G.; Burstein, H. J.; Winer, E. P.; Gnant, M.; Dubsky, P.; Loibl, S.; Colleoni, M.; Regan, M. M.; Piccart-Gebhart, M.; Senn, H. -J.; Thurlimann, B.; Andre, F.; Baselga, J.; Bergh, J.; Bonnefoi, H.; Brucker, S. Y.; Cardoso, F.; Carey, L.; Ciruelos, E.; Cuzick, J.; Denkert, C.; Di Leo, A.; Ejlertsen, B.; Francis, P.; Galimberti, V.; Garber, J.; Gulluoglu, B.; Goodwin, P.; Harbeck, N.; Hayes, D. F.; Huang, C. -S.; Huober, J.; Khaled, H.; Jassem, J.; Jiang, Z.; Karlsson, P.; Morrow, M.; Orecchia, R.; Osborne, K. C.; Pagani, O.; Partridge, A. H.; Pritchard, K.; Ro, J.; Rutgers, E. J. T.; Sedlmayer, F.; Semiglazov, V.; Shao, Z.; Smith, I.; Toi, M.; Tutt, A.; Viale, G.; Watanabe, T.; Whelan, T. J.; Xu, B. 分享 收藏
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer Rugo, Hope S.; Tredan, Olivier; Ro, Jungsil; Morales, Serafin M.; Campone, Mario; Musolino, Antonino; Afonso, Noemia; Ferreira, Marta; Park, Kyong Hwa; Cortes, Javier; Tan, Antoinette R.; Blum, Joanne L.; Eaton, Lamar; Gause, Christine K.; Wang, Zhen; Im, Ellie; Mauro, David J.; Jones, Mary Beth; Denker, Andrew; Baselga, Jose 分享 收藏
Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation 贝伐单抗联合紫杉醇与安慰剂联合紫杉醇作为HER2-negative转移性乳腺癌的一线治疗 (MERiDiAN): 一项具有前瞻性生物标志物评估的双盲安慰剂对照随机III期试验 Miles, David; Cameron, David; Bondarenko, Igor; Manzyuk, Lyudmila; Alcedo, Juan Carlos; Lopez, Roberto Ivan; Im, Seock-Ah; Canon, Jean-Luc; Shparyk, Yaroslav; Yardley, Denise A.; Masuda, Norikazu; Ro, Jungsil; Denduluri, Neelima; Hubeaux, Stanislas; Quah, Cheng; Bais, Carlos; O'Shaughnessy, Joyce 分享 收藏
Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial palbociclib联合氟维司群治疗激素受体阳性、HER2-negative转移性乳腺癌的生活质量: 来自PALOMA-3试验的患者报告结果 Harbeck, N.; Iyer, S.; Turner, N.; Cristofanilli, M.; Ro, J.; Andre, F.; Loi, S.; Verma, S.; Iwata, H.; Bhattacharyya, H.; Theall, K. Puyana; Bartlett, C. H.; Loibl, S. 分享 收藏
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress 在绝经前或化疗后恢复月经的激素敏感性乳腺癌年轻女性中，他莫昔芬增加卵巢抑制的作用 (ASTRRA): 随机对照试验的研究方案和进展 Kim, Hyun-Ah; Ahn, Sei Hyun; Nam, Seok Jin; Park, Seho; Ro, Jungsil; Im, Seock-Ah; Jung, Yong Sik; Yoon, Jung Han; Hur, Min Hee; Choi, Yoon Ji; Lee, Soo-Jung; Jeong, Joon; Cho, Se-Heon; Kim, Sung Yong; Lee, Min Hyuk; Kim, Lee Su; Moon, Byung-In; Kim, Tae Hyun; Park, Chanheun; Kim, Sei Joong; Jung, Sung Hoo; Park, Heungkyu; Gwak, Geum Hee; Kang, Sun Hee; Kim, Jong Gin; Kim, Jeryong; Choi, Su Yun; Lim, Cheol-Wan; Kim, Doyil; Yoo, Youngbum; Song, Young-Jin; Kang, Yoon-Jung; Jung, Sang Seol; Shin, Hyuk Jai; Lee, Kwan Ju; Han, Se-Hwan; Lee, Eun Sook; Han, Wonshik; Kim, Hee-Jung; Noh, Woo Chul 分享 收藏
分享 收藏
The role of skeletal muscle volume on prognosis of breast cancer survivors using with cross-sectional image Song, E. J.; Park, S. J.; Lee, M. H.; Kwon, Y.; Ko, K. L.; Lee, K. S.; Ro, J.; Jung, S. Y.; Lee, S. Y.; Kang, H. S.; Lee, E. S. 分享 收藏
PALOMA3: Phase 3 trial of fulvestrant with or without palbociclib in pre and postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy-confirmed efficacy and safety Cristofanilli, M.; Bondarenko, I.; Ro, J.; Im, S-A; Masuda, N.; Colleoni, M.; DeMichele, A. M.; Loi, S.; Verma, S.; Iwata, H.; Bartlett, C. Huang; Zhang, K.; Theall, K. Puyana; Turner, N. C.; Slamon, D. J. 分享 收藏
Updated safety from a double-blind phase 3 trial (PALOMA-3) of fulvestrant with placebo or with palbociclib in pre- and postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer that progressed on prior endocrine therapy Verma, S.; DeMichele, A. M.; Loi, S.; Ro, J.; Colleoni, M.; Iwata, H.; Harbeck, N.; Stearns, V.; Cristofanilli, M.; Bartlett, C. Huang; Schnell, P.; Zhang, K.; Thiele, A.; Turner, N. C.; Rugo, H. S. 分享 收藏
Clinical implications of proliferation activity in T1 or T2 male gastric cancer patients Kim, Young-Woo; Eom, Bang Wool; Kook, Myeong-Cherl; Kim, Han-Seong; Kim, Mi-Kyung; Hwang, Hai-Li; Chandra, Vishal; Poojan, Shiv; Song, Yura; Koh, Jae-Soo; Bae, Chang-Dae; Ro, Jungsil; Hong, Kyeong-Man 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
OAAI